Exogenous H2S mitigates myocardial fibrosis in diabetic rats through suppression of the canonical Wnt pathway
暂无分享,去创建一个
Ya Wang | Yan Chen | S. Mehmood | Shan-feng Ma | Q. Jia | R. Yang
[1] Shan-feng Ma,et al. Genistein attenuates renal fibrosis in streptozotocin-induced diabetic rats , 2018, Molecular medicine reports.
[2] M. Breschi,et al. The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury. , 2018, Current medicinal chemistry.
[3] Q. Chai,et al. Hydrogen Sulfide in Diabetic Complications: Focus on Molecular Mechanisms. , 2018, Endocrine, metabolic & immune disorders drug targets.
[4] P. Błyszczuk,et al. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. , 2018, Acta biochimica Polonica.
[5] Xiangning Cui,et al. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction , 2018, Cellular Physiology and Biochemistry.
[6] Maojun Liu,et al. Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK/STAT signaling pathway , 2018, International journal of molecular medicine.
[7] Shan-feng Ma,et al. Effect of genistein on myocardial fibrosis in diabetic rats and its mechanism , 2017, Molecular medicine reports.
[8] John B. Matson,et al. A review of hydrogen sulfide (H2S) donors: Chemistry and potential therapeutic applications , 2017, Biochemical pharmacology.
[9] Bin Zhou,et al. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] Qiyi Wang,et al. [Sodium hydrosulfide attenuates myocardial injury through activating thioredoxin system in diabetic rats]. , 2017, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
[11] Yuehua Wu,et al. EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-&bgr;/Smad3 Signaling , 2017, Circulation research.
[12] T. Force,et al. Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. , 2017, Journal of molecular and cellular cardiology.
[13] Shan-feng Ma,et al. Effects of hydrogen sulfide on inducible nitric oxide synthase activity and expression of cardiomyocytes in diabetic rats , 2017, Molecular medicine reports.
[14] Zhankui Jia,et al. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway , 2017, Cell and Tissue Research.
[15] Ruichan Liu,et al. Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. , 2017, Biochemical and biophysical research communications.
[16] Juan Shi,et al. Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis , 2017, Mediators of inflammation.
[17] D. Tănase,et al. Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets , 2017, Journal of diabetes research.
[18] Xia Li,et al. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice , 2016, Cellular Physiology and Biochemistry.
[19] Jun Li,et al. Wnt signaling pathway in cardiac fibrosis: New insights and directions. , 2016, Metabolism: clinical and experimental.
[20] W. Hozayen,et al. Protective Effect of Zingiber Officinale against CCl4-Induced Liver Fibrosis Is Mediated through Downregulating the TGF-ß1/Smad3 and NF-κB/IκB Pathways , 2015, Pharmacology.
[21] Wang-lin Jiang,et al. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway. , 2015, Pulmonary pharmacology & therapeutics.
[22] Zhang-bin Tan,et al. Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway , 2015, Therapeutics and clinical risk management.
[23] F. Salloum,et al. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability. , 2015, Pharmacology & therapeutics.
[24] Tao Zhang,et al. Hydrogen Sulfide Prevents Synaptic Plasticity from VD-Induced Damage via Akt/GSK-3β Pathway and Notch Signaling Pathway in Rats , 2015, Molecular Neurobiology.
[25] K. Yutzey,et al. Cardiac fibroblasts: from development to heart failure , 2015, Journal of Molecular Medicine.
[26] J. Bełtowski. Hydrogen sulfide in pharmacology and medicine — An update , 2015, Pharmacological reports : PR.
[27] Xiaoping Zhou,et al. Hydrogen sulfide attenuates the development of diabetic cardiomyopathy. , 2015, Clinical science.
[28] Qiyu Zhang,et al. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway , 2015, Acta Pharmacologica Sinica.
[29] Jia Liu,et al. Hydrogen Sulfide Alleviates Myocardial Collagen Remodeling in Association with Inhibition of TGF-β/Smad Signaling Pathway in Spontaneously Hypertensive Rats , 2015, Molecular medicine.
[30] Jian Luo,et al. Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters. , 2015, Bio-medical materials and engineering.
[31] D. Crossman,et al. Mechanisms underlying the impaired contractility of diabetic cardiomyopathy. , 2014, World journal of cardiology.
[32] J. Woodgett,et al. Cardiac Fibroblast Glycogen Synthase Kinase-3&bgr; Regulates Ventricular Remodeling and Dysfunction in Ischemic Heart , 2014, Circulation.
[33] Arjun Deb,et al. Cardiac fibroblast in development and wound healing. , 2014, Journal of molecular and cellular cardiology.
[34] J. Bian,et al. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. , 2014, Antioxidants & redox signaling.
[35] Wei Chen,et al. Wnt and the Wnt signaling pathway in bone development and disease. , 2014, Frontiers in bioscience.
[36] K. Kashfi,et al. Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression. , 2013, Leukemia research.
[37] A. Selicorni,et al. Cornelia de Lange Syndrome: NIPBL haploinsufficiency downregulates canonical Wnt pathway in zebrafish embryos and patients fibroblasts , 2013, Cell Death and Disease.
[38] E. Jho,et al. Wnt/β-catenin signalling: from plasma membrane to nucleus. , 2013, The Biochemical journal.
[39] Chun-jun Li,et al. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid , 2012, Cardiovascular Diabetology.
[40] S. Yuda,et al. Diabetic cardiomyopathy: pathophysiology and clinical features , 2012, Heart Failure Reviews.
[41] F. Gao,et al. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[42] J. Zwerina,et al. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway , 2011, Annals of the rheumatic diseases.
[43] J. Calvert,et al. Novel insights into hydrogen sulfide--mediated cytoprotection. , 2010, Antioxidants & redox signaling.
[44] Randall T. Moon,et al. Proximal events in Wnt signal transduction , 2009, Nature Reviews Molecular Cell Biology.
[45] B. Geng,et al. Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[46] Xuedong Liu,et al. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. , 2008, Genes & development.
[47] S. Bailey,et al. Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. , 2007, American journal of physiology. Heart and circulatory physiology.
[48] S. Anker,et al. Contributions of Inflammation and Cardiac Matrix Metalloproteinase Activity to Cardiac Failure in Diabetic Cardiomyopathy , 2007, Diabetes.
[49] C. Wolf‐peeters,et al. Loss of Membranous Expression of β-Catenin Is Associated with Tumor Progression in Cutaneous Melanoma and Rarely Caused by Exon 3 Mutations , 2002, Modern Pathology.
[50] A. Levine,et al. WISP-1 is a Wnt-1- and β-catenin-responsive oncogene , 2000, Genes & Development.
[51] A. Levine,et al. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. , 2000, Genes & development.